Benner, Axel
German Cancer Research Center
6 papers on CoChatORCID 0000-0002-7238-6956
Most cited papers
- Verified
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 1,628
- Verified
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B
Schlenk, R. F., Dohner, K., Kneba, M., Gotze, K., Hartmann, F., del Valle, F., Kirchen, H., Koller, E., Fischer, J. T., Bullinger, L., et al. (2009) · Haematologica
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 210
- Verified
Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer
Ishaque, N., Abba, M. L., Hauser, C., Patil, N., Paramasivam, N., Huebschmann, D., Leupold, J. H., Balasubramanian, G. P., Kleinheinz, K., Toprak, U. H., et al. (2018) · Nature Communications
Cancer Genomics and DiagnosticsColorectal Cancer Treatments and Studies
Cited by 132
- Verified
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
Dieter, S. M., Siegl, C., Codó, P. L., Huerta, M., Ostermann-Parucha, A. L., Schulz, E., Zowada, M. K., Martin, S., Laaber, K., Nowrouzi, A., et al. (2021) · Cell Reports
Protein Degradation and InhibitorsColorectal Cancer Treatments and Studies
Cited by 95
- Verified
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAF V600E-mutated multiple myeloma
Giesen, N., Chatterjee, M., Scheid, C., Poos, A. M., Besemer, B., Miah, K., Benner, A., Becker, N., Moehler, T., Metzler, I., et al. (2023) · Blood
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 48
- Verified
Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer
Kap, E. J., Seibold, P., Richter, S., Scherer, D., Habermann, N., Balavarca, Y., Jansen, L., Becker, N., Pfütze, K., Popanda, O., et al. (2015) · The Pharmacogenomics Journal
Genetic factors in colorectal cancerColorectal Cancer Treatments and Studies
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free